Browse Research Interests

Ageing
Allergy
Anatomy
Arthritis / Rheumatology
Arthritis
Biochemistry
Bioethics
Biological Anthropology
Biomedical Engineering
Biostatistics
Cancer
Cardiology and Vascular Disease
Cell Biology and Gene Regulation
Clinical Governance
Clinical Research
Community Medicine
Dermatology
	Professor Dedee Murrell     St George Clinical School - Department of Medicine Statement of Interests: Clinical dermatology Research • quality of life studies in blistering diseases; epidemiology of Epidermolysis bullosa and autoimmune blistering diseases in Australia; Basic/Translational research: genotype-phenotype correlations in epidermolysis bullosa • gene and cell therapy for dystrophic epidermolysis bullosa • autoantigen mapping in pemphigus and pemphigoid • squamous cell carcinoma and angiogenesis factors Dermatopharmacology Research • photodynamic therapy for non-melanoma skin cancer • trials of new therapies for psoriasis • evidence based therapies and measurement tools for blistering diseases ; Supervision of ILP students since the program started - the first student, John Frew, won the prize for the best project at the Annual Symposium at St George Hospital in 2007 (Development of a quality of life scale, the QOLEB, for EB); Yong Kho won the same prize in 2008 (Establishment of the Australasian EB Registry); all ILP students have had high distinctions and oral and poster presentations at local, national and some at International conferences, and published papers. More...
	Associate Professor Orli Wargon     School of Women's and Children's Health Statement of Interests: Retrospective review of clinical data.Review of cases of incontinentia pigmenti published November 2005 and recently updated 9.7.06 poster presentation won first prize at Society of Paediatric dermatology 32nd Annual Summer Meeting,Montreal. ILP 2007 comparative study of 2 topical corticosteroids in atopic dermatitis. Haemangioma of infancy epidemiology prospective study started 2007. ILP project in 2008 Epidemiology of infantile haemangioma: Prospective survey of newborns at RHW,survey,followup if IH develop. Haemangioma: role of monocytes at CVR at UNSW started May 2007 and continuing 2009. ILP 2009: Propranolol 2mg/kg/day for infantile haemangioma:placebo controlled double blind trial for IH presenting too late for gold standard oral corticosteroid therapy or failing to respond to gold standard therapy. More...
Diabetes
Disease Modelling
Drug Related Harm / Addiction
Embryology
Endocrinology
ENT
Epidemiology
Evidence Based Medicine
Gastrointestinal Diseases
Genetics - Genome Analysis
Gerontology - Geriatrics
Global Health
Gynaecology
Haematology
Health Policy
Health Promotion
Health Services Management
Health Services Research
HIV - AIDS
Imaging / Radiology
Immunology
Indigenous Health
Infectious Diseases
Inflammation
Injury
Lipids
Medical Education
Medical Informatics
Medical Radiation Physics
Metabolism
Molecular Structure & Drug Design
Neurodegenerative Diseases
Neurology
Neuropsychology
Neuroscience
Neurotrauma
Obesity
Obstetrics / Gynaecology
Ophthalmology
Orthopaedics
Paediatrics / Child Health
Pain
Pathology
Pharmacology
Physiology
Population Health
Preventive Medicine
Primary Health Care
Proteomics
Psychiatry
Pulmonary Disease
Rehabilitation
Renal Disease
Rural Health
Stem Cells
Surgery
Toxicology
Transplantation
Virology